1Vote!
Daily Advance - Business (Free subscription) | 06/25/2009
NEW YORK — Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration...
+Vote!
Miami Herald (Free subscription) | 06/25/2009
Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration approval for a generic version of Duramed Pharmaceuticals' Plan B emergency contraceptive.
+Vote!
Seattle Times (Free subscription) | 06/25/2009
Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration approval for a generic version of Duramed Pharmaceuticals' Plan B emergency contraceptive.
+Vote!
San Fransisco Chronicle (Free subscription) | 06/25/2009
Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration approval for a generic version of Duramed Pharmaceuticals' Plan B emergency contraceptive. The generic version is approved for prescription use only. Duramed has exclusive... Sponsored Topics: US Food and Drug Administration - Barr Pharmaceuticals - Emergency contraception - Health - United States
+Vote!
Business Pundit (Free subscription) | 06/17/2009
Image: Pharmer.org Watson Pharmaceuticals acquired Arrow Group for $1.75 billion in stock and cash today. The deal is the latest in a wave of pharmaceutical company mergers and acquisitions. Bloomberg has more: Watson Pharmaceuticals Inc. agreed to buy closely held Arrow Group for $1.75 billion in cash and stock, gaining more than 100 generic medicines. Watson, [...]
+Vote!
atHome Top Story (Free subscription) | 06/17/2009
Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock, getting access to a promising drug candidate pipeline and new markets.
+Vote!
Daily Advance - Business (Free subscription) | 06/17/2009
NEW YORK — Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker A...
+Vote!
Baltimore Sun (Free subscription) | 06/17/2009
Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock.
+Vote!
Market Watch (Free subscription) | 06/17/2009
NEW YORK (MarketWatch) -- Watson Pharmaceuticals Inc. said Wednesday that it will acquire privately held Arrow Group for $1.75 billion in cash and stock. Watson expects the transaction to close in the second half of 2009, and be accretive to cash earnings per share in 2010 before synergies. Watson said the result will be a global pharmaceutical company with over $3 billion in revenue and commercial...
+Vote!
iStockAnalyst.com (Free subscription) | 05/20/2009
This week’s hot stock from a hot sector is Watson Pharmaceuticals Inc. (WPI). Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, marketing, sale, and distribution of generic and brand pharmaceutical products primarily in the United States. Watson recently reported and earnings and provided Wall Street strong guidance for the rest of the...